BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6167342)

  • 1. Multiple biochemical markers in patients with gynecologic malignancies.
    Donaldson ES; van Nagell JR; Pursell S; Gay EC; Meeker WR; Kashmiri R; van deVoorde J
    Cancer; 1980 Mar; 45(5):948-53. PubMed ID: 6167342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical markers in the plasma and tumors of patients with gynecologic malignancies.
    van Nagell JR; Donaldson ES; Hanson MB; Gay EC; Pavlik EJ
    Cancer; 1981 Jul; 48(2 Suppl):495-503. PubMed ID: 6168368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical markers in gynaecological cancer.
    Farrell RJ
    Ir Med J; 1980 Aug; 73(8):285-6. PubMed ID: 6161106
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
    Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
    Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical localization of carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), and human chorionic gonadotropin (HCG) in cervical neoplasia.
    Bychkov V; Rothman M; Bardawil WA
    Am J Clin Pathol; 1983 Apr; 79(4):414-20. PubMed ID: 6188359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoembryonic antigen in gynecologic patients. II. Immunohistological expression.
    Fenoglio CM; Crum CP; Pascal RR; Richart RM
    Diagn Gynecol Obstet; 1981; 3(4):291-9. PubMed ID: 7338157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical localization of tumor markers in epithelial ovarian cancer.
    Casper S; van Nagell JR; Powell DF; Dubilier LD; Donaldson ES; Hanson MB; Pavlik EJ
    Am J Obstet Gynecol; 1984 May; 149(2):154-8. PubMed ID: 6202143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monitoring the course of malignant neoplasms of the genital organs in women by means of determination of blood serum level of fucose, sialic acid, CEA and AFP].
    Simm S; Markowska J; Tomaszkiewicz T; Herwichowska K; Breborowicz J
    Ginekol Pol; 1979 Dec; 50(12):1029-36. PubMed ID: 94024
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), and carcinoembryonic antigen (CEA) in malignant germ cell tumors of the ovary using immunoperoxidase technique (author's transl)].
    Obata N; Kodama S; Hando T; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):757-66. PubMed ID: 6165791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncofoetal antigens in cancer of the cervix and ovary.
    Cauchi MN; Koh SH; Lim D; Hay DL
    Br J Cancer; 1981 Sep; 44(3):403-9. PubMed ID: 6169360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical significances of carcinoembryonic proteins in patients with ovarian carcinoma.
    Tottori K; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan; 33(1):142-50. PubMed ID: 6164739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary chorionic gonadotropin subunits and beta-core in nonpregnant women. A study of benign and malignant gynecologic disorders.
    Neven P; Iles RK; Lee CL; Hudson CN; Shepherd JH; Chard T
    Cancer; 1993 Jun; 71(12):4124-30. PubMed ID: 7685240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor markers in gynecologic malignancies].
    Tojo S; Suzuki A; Fujii S; Ashitaka Y; Maruo T; Matsuura S
    Gan No Rinsho; 1983 May; 29(6):678-83. PubMed ID: 6192268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of measurement of human placental lactogen, human chorionic gonadotropin, and carcinoembryonic antigen in patients with ovarian carcinoma.
    Samaan NA; Smith JP; Rutledge FN; Schultz PN
    Am J Obstet Gynecol; 1976 Sep; 126(2):186-9. PubMed ID: 183504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The detection and measurement of oncodevelopmental proteins in gynecological malignant disease.
    Cerni C; Tatra G
    Arch Gynecol; 1982; 231(2):159-65. PubMed ID: 6176191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of alpha-fetoprotein, human chorionic gonadotropin and carcinoembryonic antigen in patients with primary intracranial germ cell tumors.
    Arita N; Ushio Y; Hayakawa T; Uozumi T; Watanabe M; Mori T; Mogami H
    Oncodev Biol Med; 1980; 1(4-5):235-40. PubMed ID: 6169060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour markers in gynaecologic oncology.
    Onsrud M
    Scand J Clin Lab Invest Suppl; 1991; 206():60-70. PubMed ID: 1719611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunohistochemical study of keratin, carcinoembryonic antigen, human chorionic gonadotropin and alpha-fetoprotein in lung cancer.
    Kimura N; Ghandur-Mnaymen L
    Tohoku J Exp Med; 1985 Jan; 145(1):23-38. PubMed ID: 2580364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on tissue-localization of various tumormarkers in ovarian tumors by immunoperoxidase method].
    Tanimura T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2344-52. PubMed ID: 2416855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of CEA, AFP, SP1 and HCG as tumor markers in ovarian carcinoma.
    Pulay T; Csömör S; Mészáros K; Szarka G; Csabay L; Szinnyai A
    Neoplasma; 1987; 34(5):595-600. PubMed ID: 2447510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.